List of Oncology Medication For
Solid Tumors
Treatment for solid tumors depends on several factors, including the type and stage of the tumor, its location, and the patient’s overall health. Treatment options may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these approaches.
IMDELLTRA (tarlatamab-dlle) for injection
Brand Name: IMDELLTRA Generic Name: tarlatamab-dlle IMDELLTRA (tarlatamab-dlle) is used to treat adult patients with extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.
On May 16, 2024, the Food and Drug Administration granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen, Inc.) for extensive stage small cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy.
| Brand Name: | IMDELLTRA |
| Generic Name: | tarlatamab-dlle |
| Strength: | • 1 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution. • 10 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution. |
| Manufacturer: | Amgen Inc. |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “IMDELLTRA (tarlatamab-dlle)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for IMDELLTRA (tarlatamab-dlle) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
IMDELLTRA (tarlatamab-dlle) for injection
IMDELLTRA (tarlatamab-dlle) – Lung Cancer Therapy in India
It is indicated for treating adults with extensive-stage small cell lung cancer (ES-SCLC) whose disease progressed after or during platinum-based chemotherapy, functioning as a bispecific T-cell engager to target DLL3-expressing cancer cells. It’s approved under accelerated FDA approval, with ongoing trials to confirm clinical benefit.
| Brand Name: | IMDELLTRA |
| Generic Name: | tarlatamab-dlle for injection |
| Strength: | • For injection: 1 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution. • For injection: 10 mg of lyophilized powder in a single-dose vial for reconstitution and further dilution. |
| Manufacturer: | Amgen Inc |
| Approved By: | EMA, USFDA |
Source Details: Patient Information.
Access IMDELLTRA for Lung Cancer on a Named Patient Import Basis
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to IMDELLTRA (tarlatamab-dlle) For Injection for personal use. To proceed, the applicant must submit an application in Form 12A along with a valid prescription issued by a Registered Medical Practitioner (RMP).
For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
Note: All access is provided strictly on a Named Patient Import Basis and for personal use only, in accordance with Indian regulatory guidelines.
Imetelstat for injection
Salt Name: imetelstat. It is used to treat patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS).
RYTELO is an oligonucleotide telomerase inhibitor indicated for the treatment of adult patients with low-to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent anemia requiring 4 or more red blood cell units over 8 weeks who have not responded to or have lost response to or are ineligible for erythropoiesis-stimulating agents (ESA).
| Generic Name: | imetelstat |
| Strength: | • For injection: 47 mg powder in a single-dose vial for reconstitution. • For injection: 188 mg powder in a single-dose vial for reconstitution. |
| Manufacturer: | Geron Corporation |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “RYTELO (imetelstat)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for RYTELO (imetelstat) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
INLURIYO (imlunestrant) tablets
Ipilimumab Injection
ipilimumab injection,
for intravenous use Initial U.S. Approval: 2011
Yervoy (ipilimumab) is a kinase inhibitor indicated for the treatment of advanced (unresectable or metastatic) melanoma.
Facts about Ipilimumab Injection
API: ipilimumab
Trade Name: On Request
Packaging: injection, for intravenous use
Strength: Injection: 50 mg/10 mL (5 mg/mL) and 200 mg/40 mL (5 mg/mL) in a single-use vial.
DISEASE INDICATIONS-Urothelial Carcinoma, Skin Cancer
MANUFACTURER-Bristol-Myers Squibb
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ipilimumab Injection” based on the information you provide.
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
Ixekizumab injection
ixekizumab injection
for subcutaneous use Initial U.S. Approval: 2016
ixekizumab injection is a humanized interleukin-17A antagonist indicated for the treatment of: • patients aged 6 years or older with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. • adults with active psoriatic arthritis. • adults with active ankylosing spondylitis. • adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation.
Facts about ixekizumab injection
DISEASE INDICATIONS-Psoriasis
MANUFACTURER-Eli Lilly Nederland B.V.
USAGE-Subcutaneous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import ixekizumab injection” based on the information you provide.
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
IXEMPRA Kit (ixabepilone) for Injection
IXEMPRA Kit (ixabepilone) for injection, for intravenous use Initial U.S. Approval: 200
XEMPRA is a prescription medicine. IXEMPRA is used to treat breast cancer. • IXEMPRA, a microtubule inhibitor, in combination with capecitabine is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline and a taxane. • IXEMPRA as monotherapy is indicated for the treatment of metastatic or locally advanced breast cancer in patients after failure of an anthracycline, a taxane and capecitabine. .
| Brand Name: | IXEMPRA Kit |
| Generic Name: | ixabepilone |
| Strength: | • IXEMPRA for injection, 15 mg supplied with DILUENT for IXEMPRA, 8 mL • IXEMPRA for injection, 45 mg supplied with DILUENT for IXEMPRA, 23.5 mL |
| Manufacturer: | R-Pharm |
| Approved By: | EMA, USFDA |
Source content : www.accessdata.fda.gov
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import IXEMPRA Kit (ixabepilone) for Injection” based on the information you provide.
Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
JASCAYD (nerandomilast tablets)
JAYPIRCA (pirtobrutinib) tablets
Brand Name: JAYPIRCA Generic Name: pirtobrutinib JAYPIRCA (pirtobrutinib) is used for treatment of Adult patients with relapsed or refractory mantle cell lymphoma (MCL)
Jaypirca is a cancer medicine used to treat adults with mantle cell lymphoma (a cancer of B cells, a type of white blood cell) whose cancer has come back (relapsed) or no longer responds to treatment (refractory), and who had previously received a type of cancer medicine called a Bruton’s tyrosine kinase (BTK) inhibitor.
| Brand Name: | JAYPIRCA |
| Generic Name: | pirtobrutinib |
| Strength: | Tablets: 50 mg, 100 mg |
| Manufacturer: | Eli Lilly and Company |
| Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “JAYPIRCA (pirtobrutinib)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for JAYPIRCA (pirtobrutinib) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.
Contact Info
CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
info@indianpharmanetwork.co.in
FAX NUMBER:
+91-11-26532129
Query Form For Medications
Note
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
Disclaimer
“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.
Privacy Policy
Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network
Health Information
“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.
Shipped Anti-Cancer Medicines.
Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in